YesYou can take a few things out of this and expand.IE''Inavir?...

Yes

You can take a few things out of this and expand.


IE

''Inavir? is the first drug of a new class of long acting neuraminidase inhibitors (LANIs) to address the limitation of the current products''

So as you say Outawater. More to come !!! I know of no other LANIs in development.


''Biota and Daiichi Sankyo co-own a range of second generation influenza anti-virals''

WOW.I will need to research what varients of INAVIR you may get.


Jessie, for you. Huge ramifaction re storage and effective use.

''the patient is more likely to use the product properly and as intended and also offers a reduced cost of storage and transport per course, where the product is intended to be stockpiled.''




And of course.

''Biota and Daiichi Sankyo are exploring options for development and commercialisation of laninamivir ex-Japan.''


The plot thickens.